MicroRNAs miR-23a-3p, miR-23b-3p, and miR-149-5p Regulate the Expression of Proapoptotic BH3-Only Proteins DP5 and PUMA in Human Pancreatic β-Cells
Year: 2016
Type: article
Abstract: Type 1 diabetes (T1D) is an autoimmune disease leading to β-cell destruction. MicroRNAs (miRNAs) are small noncoding RNAs that control gene expression and organ formation. They participate in the pathogenesis of several autoimmune diseases, but the nature of miRNAs contributing to β-cell death in T1D and their target genes remain to be clarified. We performed an miRNA expression profile on human islet preparations exposed to the cytokines IL-1β plus IFN-γ. Confirmation of miRNA and target gene modification in human β-cells was performed by real-time quantitative PCR. Single-stranded miRNAs inhibitors were used to block selected endogenous miRNAs. Cell death was measured by Hoechst/propidium iodide staining and activation of caspase-3. Fifty-seven miRNAs were detected as modulated by cytokines. Three of them, namely miR-23a-3p, miR-23b-3p, and miR-149-5p, were downregulated by cytokines and selected for further studies. These miRNAs were found to regulate the expression of the proapoptotic Bcl-2 proteins DP5 and PUMA and consequent human β-cell apoptosis. These results identify a novel cross talk between a key family of miRNAs and proapoptotic Bcl-2 proteins in human pancreatic β-cells, broadening our understanding of cytokine-induced β-cell apoptosis in early T1D.
Source: Diabetes
DOI: 10.2337/db16-0592
Language: English
Subfield: Cancer Research
Domain: Life Sciences
Open Access status: bronze
Funders: Leona M. and Harry B. Helmsley Charitable Trust, European Federation of Pharmaceutical Industries and Associations, Human Islet Research Network, European Commission, National Institutes of Health, ULB Center for Diabetes Research, National Institute of Diabetes and Digestive and Kidney Diseases
Awards: Development of a systems biomedicine approach for risk identification, prevention and treatment of type 2 diabetes, Biomarkers Of Beta Cell Stress In Type 1 Diabetes (BetaMarker), G434337789, Translational approaches to disease modifying therapy of type 1 diabetes: an innovative approach towards understanding and arresting type 1 diabetes – Sofia ref.: 115797, G7696965656
OpenAlex ID: W2530874554
